This type of diagnostic examination is designed to identify the presence of four specific substances, or classes of substances, within a biological sample. For example, such a test might screen for cannabinoids, opioids, amphetamines, and cocaine metabolites in urine. The results of this testing are commonly used in pre-employment screenings, workplace monitoring, and clinical settings.
The implementation of a limited substance panel offers several advantages, including reduced testing costs compared to broader panels, faster turnaround times for results, and a focused assessment aligned with specific risk factors or regulatory requirements. Its historical context is rooted in the need for targeted and cost-effective substance abuse detection methods, evolving as technology advanced and specific drug trends emerged.